ONCOLOGY

MMG's first client, in 1987, was the National Cancer Institute (NCI). We continue to support NCI and its Center for Cancer Research, promoting its trials and recruiting participants through multiple, integrated strategies. Over the past 21 years, MMG has expanded this work with large and small, private and public-sector organizations, making oncology MMG’s largest therapeutic practice.

Our oncology program is led by Jeff Goldfarb and a dedicated team of clinical trial and health communications professionals. They know the unique challenges and behavioral characteristics of people with cancer. Our outreach delivers information when and where people with cancer seek it – on the Web, through advocacy groups, and from their physicians.

INDICATIONS Breast, Cancer-related anemia, CINV, Colorectal, Head & Neck, Melanoma, Non-Hodgkin’s lymphoma, Non-small cell lung, Oral mucositis, Pancreatic, Peripheral sensory neuropathy, Prostate cancer vaccine, Prostate, NSCLC, T-cell lymphoma, NCI Intramural trials
COUNTRIES Argentina, Australia, Belgium, Brazil, Canada, Chile, Colombia, Croatia, Czech Republic, Denmark, Ecuador, France, Georgia, Germany, Greece, Honduras, Hong Kong, Hungary, India, Israel, Italy, Latvia, Lithuania, Mexico, Peru, Philippines, Poland, Russia, Singapore, Slovak Republic, S. Africa, S. Korea, Spain, Taiwan, Ukraine, UK, USA	Jeff Goldfarb Vice President, Oncology Case studies Request a proposal